TC

Todd Creech

HealthQuest Capital

Tampa, Florida

Overview 

Todd Creech is an Entrepreneur in Residence and Partner at HealthQuest Capital in Tampa, Florida, with expertise in mergers, venture capital, and strategic financial planning. He has served on the boards of various healthcare and biotechnology companies, including BioIQ, and has made significant investments in Series B stage startups in sectors such as diagnostics and digital health. Creech's career highlights include his role at HealthQuest Capital, where he has made impactful investments in innovative healthcare companies, and his diverse board memberships across the healthcare and biotechnology sectors, showcasing his strategic leadership and expertise in corporate development.

Work Experience 

  • Entrepreneur in Residence

    2023 - Current

  • Partner

    2016 - 2023

    Healthcare venture growth fund focused on medical products, devices, diagnostics, consumer health, and healthcare IT.

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

  • Board Member

    2023

    Radius XR is an innovative technology company that has developed a portable vision diagnostic and patient engagement system that combines medical-grade diagnostics, business management, and patient education tools in a proprietary, stylish, wearable XR headset. Radius has developed a total hardware and software system that performs with accuracy, equips staff to work at unprecedented levels of efficiency and broadens patients’ view of the full range of services a physician practice can provide.

  • Board Observer

    2022

    Magnolia’s FDA cleared Steripath product platform focuses on improving clinical care through the reduction of “false positives” in blood culture tests for infectious disease

Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.

Raised $117,328,098.00 from SightLine Partners, Sectoral Asset Management, RTW Investments, Janus Henderson Investors, HealthQuest Capital and Evidity Health Capital.

  • Board Member

    2019

    Etairos is a licensed home health agency whose mission is to partner with its patients to deliver the very best home-based care and health outcomes while elevating each patient’s longevity, independence, safety and dignity at home.

  • Board Member

    2017 - 2024

    Alcresta develops novel products that deliver enzymatic solutions to those living with rare diseases. Alcresta's initial product platform, Relizorb, reliably and efficiently helps deliver nutritional and caloric benefit from existing enteral feeding formulas for those patients.

  • Board Member

    2022 - 2023

    ScribeAmerica is the nation's largest and most progressive Medical Scribe Company, serving over 4,000 partners in all 50 states. With expertise in emergency medicine, hospitalist, outpatient and post-acute, SA provides in-person, telescribe, and ambient AI scribe services.

Interested in stationary and remote medical scribe jobs from all over the states? Visit the JobsScribeAmerica platform!

  • Board Observer

    2021 - 2023

    Lunit is an AI driven imaging, diagnostics and digital pathology company with the mission to better detect and screen for cancer using imaging in combination with liquid biopsy. The company has developed a digital pathology / biomarker discovery platform that can also support biopharma drug development IPO on Korean Exchange - 7/2022

  • Board Observer

    2018 - 2023

    The nation’s leading employer-facing health intelligence software. Today, over 4,000 employers use Springbuk’s software to glean actionable insights to improve their population’s health.

Springbuk provides a health analytics software solution to prevent disease with data.

Raised $42,416,668.00 from Randy Scott.

  • Board Observer

    2017 - 2023

    Venus Concept (VERO) is a leading medical aesthetic device company that has developed a suite of non-invasive devices that are used in more than 10 million treatments performed worldwide annually.

  • Board Member

    2018 - 2022

    BioIQ provided a single-source testing and testing management platform driving health plan quality initiatives value-based care initiatives and employer COVID testing and return-to-work solutions. Sold to LetsGetChecked May 2022

BioIQ is a health improvement technology company that optimizes investments in corporate health and wellness programs.

Raised $42,628,942.00 from Savitr Capital, HealthQuest Capital, Arboretum Ventures, Persistence Partners and Persistence Partners.

Articles About Todd

Relevant Websites